Amylyx Pharmaceuticals: Q4 Earnings Insight And PHOENIX Trial Implications (NASDAQ:AMLX)

DNY59 Investors Breathe a Sigh of Relief Post-Earnings, Look Forward to PHOENIX Data Amylyx Pharmaceuticals (NASDAQ:AMLX) has bounced back recently. Its stock is 50% higher since my rating downgrade (from “Strong Buy” to “Buy”) in November. The rating downgrade reflected increasing caution due to operational challenges, yet it still acknowledged the apparent undervaluation. After disappointing…

Read More

FTX SBF’s Trial Reaches Final Stages, What’s Next?

Bankman-Fried’s legal team, led by Mark Cohen and Christian Everdell, has encountered difficulties in presenting a coherent narrative to the jurors. FTX co-founder Sam Bankman-Fried‘s trial is nearing its conclusion, with the prosecution set to conclude their case on October 26 after nearly 20 testimonies. The prosecution has called upon a wide range of witnesses…

Read More

Evaluating Marinus: Ztalmy’s Growth And Upcoming Trial Insights (NASDAQ:MRNS)

fmajor/E+ via Getty Images Introduction Marinus Pharmaceuticals (NASDAQ:MRNS), focusing on seizure disorders, got FDA approval in 2022 for Ztalmy (ganaxolone) to treat seizures in CDD patients over two. Ganaxolone, affecting GABAA receptors, shows anti-seizure effects. Marinus aims to expand its use and application methods. In my most recent analysis of Marinus, I highlighted their strategic…

Read More

NovoCure: TTFields’ Ovarian Trial Short-Circuits (NASDAQ:NVCR)

Dorin Puha/iStock via Getty Images Introduction NovoCure (NASDAQ:NVCR) is a healthcare firm specializing in cancer treatments. They’ve developed a unique technology called Tumor Treating Fields (TTFields) that employs electric fields to target and kill cancer cells. Their main aim is to expand the use of their FDA-sanctioned devices, Optune and Optune Lua, which treat glioblastoma…

Read More

US Federal Prosecutor Wants SBF Jailed before October Trial for Witness Intimidation

New York Federal Prosecutor asked Judge Lewis Kaplan to jail former FTX boss SBF for crossing the line after giving journalists personal writings by Caroline Ellison. The investigations of FTX and Alameda Research collapse have significantly unraveled the rot that was orchestrated by Sam Bankman-Fried (SBF) in squandering investors’ and customers’ funds. Hiding in the…

Read More